Trishul (Ayurvedic medicine) for rectal cancer before standard treatment
Part of Cancer, Digestive system clinical trials.
This study tests an Ayurvedic medicine called Trishul given before standard chemoradiation and surgery for rectal cancer. It aims to see if Trishul can help shrink the tumor and improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a type of rectal cancer called adenocarcinoma.
- Your cancer is at a stage where it has grown into or through the rectal wall (T3 or T4) or has spread to nearby lymph nodes, but not to other organs.
- You are healthy enough to receive standard treatment (chemoradiation and surgery) before the trial.
- You have not had previous radiation, chemotherapy, or Ayurvedic therapy for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding TAS-102 (a chemotherapy medicine) to radiation given before treatment improves outcomes for certain locally advanced rectal cancers. It may help by trying to shrink the tumor before the next steps of care.
This trial tests a new drug called SHR-1701 combined with standard chemotherapy and radiation for people with locally advanced rectal cancer. The goal is to shrink the tumor before surgery, making it easier to remove completely.
This trial tests whether a combination of chemotherapy, radiation, and an immunotherapy drug (tislelizumab) before surgery can improve outcomes for people with locally advanced rectal cancer that has specific protein/gene markers (pMMR or MSS). It’s designed for those who have not yet had any treatment for their cancer.
This trial studies whether adding SHR-1701 to standard chemotherapy and long-course radiation can improve treatment for locally advanced rectal cancer that can be removed by surgery. It’s mainly for people who have not had prior rectal cancer treatment and who fit several health and cancer-spread requirements.
This trial tests a combination of chemotherapy and an immunotherapy drug (a PD-1 inhibitor) given before surgery for locally advanced rectal cancer. The goal is to see if this approach can improve outcomes compared to standard treatment.
This trial tests if a highly absorbable form of curcumin (a natural compound from turmeric) added to standard chemoradiation before surgery can improve outcomes for people with mid-to-low rectal cancer. The study will also look at tumor tissue to understand how the treatment works.
Hear when a new Efficacy of Trishul trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.